Skip to content

Viral Dynamics and Transmission of Influenza, RSV and SARS-CoV-2 in Children

Influenza | RSV Infection | SARS CoV 2 Infection

Viral respiratory tract infections are very common in children. They contribute to missed time in school, work disruption for caregivers and can also cause severe illness requiring hospitalization and rarely death. In the 2022-2023, influenza, RSV and SARS-CoV-2 viruses infected a large number of children which strained the pediatric healthcare system in many jurisdictions. Unfortunately, there continues to be limited data on duration of infectiousness and transmission risk of these viruses to inform public health decisions during times when there is significant circulation of these viruses.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    1 and up

Critères de participation

Inclusion Criteria:

Viral dynamics (primary outcome):

* The child must be less than 18 years of age
* Have a positive PCR sample for influenza, RSV or SARS-CoV-2,
* Have any one of the symptoms listed to meet testing eligibility: fever, cough, shortness of breath, decreased or loss of taste or smell, muscle aches/joint pains (unusual, long lasting, not related to injury), extreme tiredness (unusual fatigue not otherwise explained), sore throat, runny or stuffy/congested nose, headache (new, unusual, long-lasting), nausea/vomiting and/or diarrhea, and
* Be within 5 days of symptom onset

Household testing inclusion criteria (secondary outcome):

-Any individual in the same household (i.e. household contacts, defined as residing at the same address) as the individual testing positive by PCR for influenza, RSV or SARS-CoV-2

Classroom testing inclusion criteria (secondary outcome):

-Any individual in the same classroom (i.e. classroom contacts) as the individual testing positive by PCR for influenza, RSV or SARS-CoV-2 (i.e. case identified through the THS program)

Exclusion Criteria:

Viral dynamics (primary outcome):

-Participants will be ineligible if they are more than 5 days from symptom onset

Lieu de l'étude

The Hospital for Sick Children (SickKids)
The Hospital for Sick Children (SickKids)
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Michelle Science

[email protected]
416-813-7654 X401157
Backup Contact

MIchelle Science, MD, MSc

Étude parrainée par
The Hospital for Sick Children
Participants recherchés
Plus d'informations
ID de l'étude: NCT06640387